Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.5M | Buy |
+658,000
| New | +$34.8M | 0.01% | 900 |
|
|
2022
Q1 | – | Sell |
-340,000
| Closed | -$18.7M | – | 6441 |
|
|
2021
Q4 | $18.7M | Buy |
+340,000
| New | +$17.7M | 0.01% | 1040 |
|
|
2021
Q1 | – | Sell |
-67,840
| Closed | -$3.12M | – | 6717 |
|
|
2020
Q4 | $3.12M | Buy |
67,840
+10,560
| +18% | +$485K | ﹤0.01% | 2438 |
|
|
2020
Q3 | $2.69M | Sell |
57,280
-49,920
| -47% | -$2.5M | ﹤0.01% | 2382 |
|
|
2020
Q2 | $5.47M | Sell |
107,200
-8,800
| -8% | -$451K | ﹤0.01% | 1787 |
|
|
2020
Q1 | $5.49M | Sell |
116,000
-64,880
| -36% | -$3.46M | 0.01% | 1585 |
|
|
2019
Q4 | $10.6M | Sell |
180,880
-7,120
| -4% | -$396K | 0.01% | 1443 |
|
|
2019
Q3 | $10M | Buy |
188,000
+720
| +0.4% | +$37K | 0.01% | 1393 |
|
|
2019
Q2 | $9.37M | Sell |
187,280
-12,800
| -6% | -$642K | 0.01% | 1437 |
|
|
2019
Q1 | $10.5M | Sell |
200,080
-15,920
| -7% | -$796K | 0.01% | 1242 |
|
|
2018
Q4 | $10.3M | Buy |
216,000
+79,440
| +58% | +$3.91M | 0.01% | 1238 |
|
|
2018
Q3 | $6.86M | Buy |
136,560
+28,400
| +26% | +$1.44M | 0.01% | 1567 |
|
|
2018
Q2 | $5.45M | Sell |
108,160
-33,600
| -24% | -$1.69M | 0.01% | 1751 |
|
|
2018
Q1 | $6.93M | Buy |
141,760
+3,360
| +2% | +$156K | 0.01% | 1503 |
|
|
2017
Q4 | $6.14M | Buy |
138,400
+64,800
| +88% | +$2.99M | ﹤0.01% | 1648 |
|
|
2017
Q3 | $3.73M | Buy |
73,600
+21,600
| +42% | +$1.1M | ﹤0.01% | 2036 |
|
|
2017
Q2 | $2.8M | Buy |
52,000
+12,160
| +31% | +$648K | ﹤0.01% | 2232 |
|
|
2017
Q1 | $2.1M | Sell |
39,840
-439,680
| -92% | -$22.3M | ﹤0.01% | 2433 |
|
|
2016
Q4 | $23.1M | Buy |
479,520
+334,640
| +231% | +$16.5M | 0.02% | 688 |
|
|
2016
Q3 | $7.81M | Sell |
144,880
-3,920
| -3% | -$215K | 0.01% | 1274 |
|
|
2016
Q2 | $8.06M | Sell |
148,800
-3,840
| -3% | -$202K | 0.01% | 1187 |
|
|
2016
Q1 | $7.74M | Sell |
152,640
-82,000
| -35% | -$4.08M | 0.01% | 1188 |
|
|
2015
Q4 | $11.8M | Buy |
234,640
+10,960
| +5% | +$559K | 0.01% | 1045 |
|
|
2015
Q3 | $10.8M | Sell |
223,680
-60,640
| -21% | -$3.16M | 0.01% | 1090 |
|
|
2015
Q2 | $14.8M | Buy |
284,320
+75,360
| +36% | +$4.24M | 0.01% | 964 |
|
|
2015
Q1 | $12.1M | Sell |
208,960
-71,120
| -25% | -$4.08M | 0.01% | 1053 |
|
|
2014
Q4 | $15M | Sell |
280,080
-77,600
| -22% | -$4.34M | 0.01% | 978 |
|
|
2014
Q3 | $20.6M | Buy |
357,680
+101,760
| +40% | +$6.24M | 0.02% | 788 |
|
|
2014
Q2 | $17.1M | Buy |
255,920
+88,960
| +53% | +$6.02M | 0.02% | 891 |
|
|
2014
Q1 | $11.2M | Sell |
166,960
-66,160
| -28% | -$4.47M | 0.01% | 1074 |
|
|
2013
Q4 | $15.6M | Sell |
233,120
-10,880
| -4% | -$705K | 0.01% | 911 |
|
|
2013
Q3 | $15.3M | Buy |
244,000
+7,680
| +3% | +$494K | 0.01% | 864 |
|
|
2013
Q2 | $14.8M | Buy |
+236,320
| New | +$15M | 0.01% | 824 |
|
Other funds holding GSK
JEST
Citigroup's GSK Position: Q2 2026 in Review
Citigroup reduced its GSK (GSK) stake by 77% in Q2 2026, selling an estimated $60.9M and leaving 343,989 shares worth $18M. The position accounts for 0.01% of the portfolio, ranked #1220.
Citigroup first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $103M in Q1 2024. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Citigroup held 343,989 shares of GSK worth $18M as of Q2 2026.
- Citigroup sold 1,152,108 GSK shares in Q2 2026, an estimated $60.9M.
- GSK made up 0.01% of Citigroup's portfolio in Q2 2026, its #1220 holding.
- Citigroup first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Citigroup's GSK position peaked at $103M in Q1 2024.
- 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.